Abstract:In the present study,we aimed to study the action mechanism of Mongolian medicine Herba Lomatognii on acute liver injury(ALI)using network pharmacology and bioinformatics methods to provide a reference for further study of Herba Lomatognii on metabolic diseases.Herba Lomatognii showed protective effects on D-GlaN-induced ALI model rats,which were used to analyze serum transaminase and enzyme-linked immunosorbent assay changes.The chemical constituents of Herba Lomatognii and their corresponding targets were collected by TCMSP database and literature search.ALI targets were compiled by GenCards and DisGeNet disease databases,and the targets of active constituents of Herba Lomatognii were interesting ALI targets.The obtained targets were targets of Herba Lomatognii against ALI.The Metascape database was used to do a Go function and KEGG pathway enrichment analysis of consensus targets,and Cytoscape software was used to create a correlation network diagram.Validation of molecular docking was carried out by analyzing important core components and significant targets.In addition,Western blotting analysis was utilized to detect transcription activator 3(STAT3),AKT1,and CASP3 expressions in the rat liver.Serum transaminases and enzyme-linked immunostaining assay demonstrated that Herba Lomatognii had preventive and anti-inflammatory effects on D-GlaN-induced ALI in rats.From network pharmacology screening,a total of 10 active ingredients of Herba Lomatognii and 289 corresponding targets were identified,843 targets of ALI and 89 targets of both,and GO enrichment and KEGG pathway analysis revealed that the common targets were mostly related to cancer,PI3K-Akt signaling pathway,Ras signaling pathway,HIF-1 signaling pathway,TNF-α signaling pathway,toll-like receptor signaling pathway,MAPK signaling pathway,VEGF signaling pathway,p53 signaling pathway,and NF-κB signaling pathway.Molecular docking results showed that the core components,such as swetiamain,luteolin,and kaempferol,could dock well with the targets of EGFR,SRC,AKT1,STAT3,and CASP3.The expressions of AKT1,STAT3,and CASP3 proteins in the liver tissues of model rats were considerably higher compared with the normal control rats based on Western blotting data(P＜0.05).In contrast to the model group,the AKT1 and STAT3 protein expressions in the liver tissues of the positive group and the Herba Lomatognii low-,medium-,and high-dose groups were significantly decreased(P＜0.05).Compared with the model group,the CASP3 protein expression in the liver tissue of the middle-and high-dosage groups of Herba Lomatognii was significantly lower,and no significant difference was observed in the liver tissue of the low-dosage group of Herba Lomatognii(P＞0.05).Herba Lomatognii contained potential therapeutic agents for ALI and could interfere with the development of ALI through multi-target and multi-pathway approaches.

Application of Animal Models for the Discovery and Efficacy Evaluation of Anti Acute Liver Injury in Chinese Medicine

Reach Progress on Animal Models with Hepatic Fibrosis and Its Application in Efficacy Evaluation of Traditional Chinese Medicine

Advances in Establishment of Animal Models with Hepatic Cirrhosis and Thinking about Efficacy Evaluation of Traditional Chinese Medicine

Overview and Application in Establishing Animal Models against Fatty Liver Disease for Active Discovery and Efifcacy Evaluation of Chinese Medicine

[Research on Rat Models of Acute Liver Injury with Syndrome of Liver Depression and Spleen Deficiency].

Evaluation on three short-term animal models of alcoholic liver disease

Research progress on rodent models and its mechanisms of liver injury

Research Progress on the Mechanism of Traditional Chinese Medicine in the Treatment of Non-Alcoholic Fatty Liver Disease Based on Oxidative Stress

Advances in Establishments of Animal Models with Kidney-Yang Deficiency Syndrome and Thinking about Efficacy Evaluation of Traditional Chinese Medicine

Autophagy regulation is an effective strategy to improve the prognosis of chemically induced acute liver injury based on experimental studies

Animal Models of Chronic Liver Diseases.

Research and Application of Hepatotoxicity Evaluation Technique of Traditional Chinese Medicine

Application of herbs and active ingredients ameliorate non-alcoholic fatty liver disease under the guidance of traditional Chinese medicine

The Progress to Establish Optimal Animal Models for the Study of Acute-on-chronic Liver Failure

Study on the mechanism of Mongolian medicine Herba Lomatognii against acute liver injury based on network pharmacology

Amelioration of alcohol-induced acute liver injury in C57BL/6 mice by a mixture of TCM phytochemicals and probiotics with antioxidative and anti-inflammatory effects

Research Progress on the Animal Models of Drug-Induced Liver Injury: Current Status and Further Perspectives

Advances on Mechanism Research of Traditional Chinese Prescription for the Treatment of Acute Lung Injury

Research advances in animal models of nonalcoholic fatty liver disease

Advancements in the Alcohol-Associated Liver Disease Model

Biomarkers, signaling pathways, and programmed cell death in acute lung injury and its treatment with Traditional Chinese Medicine: a narrative review